General Information of Disease (ID: DIS73X4W)

Disease Name GNE myopathy
Synonyms
inclusion body myopathy 2, autosomal recessive; quadriceps sparing myopathy; inclusion body myopathy, autosomal recessive; inclusion body myopathy, quadriceps-sparing; Nonaka distal myopathy; inclusion body myopathy 2, autosomal recessive, formerly; inclusion body myopathy, hereditary, autosomal recessive; NM; rimmed vacuole myopathy; myopathy, distal, with rimmed vacuoles; myopathy, distal, with or without rimmed vacuoles; QSM; distal myopathy with rimmed vacuoles; distal myopathy, Nonaka type; inclusion body myopathy autosomal recessive; Nonaka myopathy; hereditary inclusion body myopathy type 2; IBM2; DMRV; inclusion body myopathy type 2; HIBM2; quadriceps-sparing myopathy
Definition
Nonaka distal myopathy (described in Japan) and the quadriceps-sparing autosomal recessive inclusion body myopathy type 2 (IBM2; independently described in Iranian Jews and later in other Jewish and non-Jewish populations) constitute the same pathological entity, distinguished by the sparing of quadriceps.
Disease Hierarchy
DISAWDAB: Congenital hematological disorder
DISO85MT: Disorder of multiple glycosylation
DISFXMTP: Syndromic constitutional thrombocytopenia
DISZXXG5: Inclusion body myositis
DISDUT8O: Hereditary inclusion-body myopathy
DIS73X4W: GNE myopathy
Disease Identifiers
MONDO ID
MONDO_0011603
MESH ID
C536816
UMLS CUI
C1853926
OMIM ID
605820
MedGen ID
381298
Orphanet ID
602
SNOMED CT ID
702382000

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)
This Disease Is Related to 14 DTT Molecule(s)
Gene Name DTT ID Evidence Level Mode of Inheritance REF
BACE1 TTJUNZF Limited Altered Expression [1]
BACE2 TT69DB8 Limited Altered Expression [1]
CFP TTLA0VS Limited Biomarker [2]
CYP11A1 TTSYVO6 Limited Altered Expression [3]
GNE TT4DP5S Limited Genetic Variation [4]
HNRNPA2B1 TT8UPW6 Limited Genetic Variation [5]
PRDX4 TTPBL9I Limited Altered Expression [6]
SCN11A TTN9VTF Limited Genetic Variation [7]
VIPR2 TT4O5P0 Limited Altered Expression [8]
KIR2DL3 TTEX3SI moderate Biomarker [9]
RENBP TTZCG0Q Strong Genetic Variation [10]
SQSTM1 TTOT2RY Strong Genetic Variation [11]
GNE TT4DP5S Definitive Autosomal recessive [12]
VCP TTHNLSB Definitive Genetic Variation [13]
------------------------------------------------------------------------------------
⏷ Show the Full List of 14 DTT(s)
This Disease Is Related to 1 DTP Molecule(s)
Gene Name DTP ID Evidence Level Mode of Inheritance REF
ATP7A DT0LT17 Strong Genetic Variation [10]
------------------------------------------------------------------------------------
This Disease Is Related to 1 DME Molecule(s)
Gene Name DME ID Evidence Level Mode of Inheritance REF
SMOX DEOH5V3 Limited Biomarker [14]
------------------------------------------------------------------------------------
This Disease Is Related to 12 DOT Molecule(s)
Gene Name DOT ID Evidence Level Mode of Inheritance REF
ACTA1 OTOVGLPG Limited Biomarker [15]
ACTN2 OT9FOLD7 Limited Genetic Variation [16]
ACTR2 OT3C8U5T Limited Altered Expression [17]
AIP OTDJ3OSV Limited Biomarker [18]
CAV3 OTWSFDB4 Limited Biomarker [19]
DNAJB6 OTMHIIAN Limited Biomarker [5]
GRHL3 OT1V4ZEH Limited Biomarker [20]
MYOT OTCEW5XW Limited Genetic Variation [21]
PIP OTH719AH Limited Genetic Variation [22]
TNNT1 OT8PBOAR Limited Biomarker [23]
CLTA OTLHOXMQ Strong Genetic Variation [24]
GNE OTNONPMB Definitive Autosomal recessive [12]
------------------------------------------------------------------------------------
⏷ Show the Full List of 12 DOT(s)

References

1 BACE1 and BACE2 in pathologic and normal human muscle.Exp Neurol. 2003 Feb;179(2):150-8. doi: 10.1016/s0014-4886(02)00025-0.
2 Complement factor P is a ligand for the natural killer cell-activating receptor NKp46.Sci Immunol. 2017 Apr 28;2(10):eaam9628. doi: 10.1126/sciimmunol.aam9628.
3 The effect of insulin and insulin-like growth factors on the expression of steroidogenic enzymes in a human ovarian thecal-like tumor cell model.Fertil Steril. 1996 Jan;65(1):87-93. doi: 10.1016/s0015-0282(16)58032-7.
4 Clinical utility of RNA sequencing to resolve unusual GNE myopathy with a novel promoter deletion.Muscle Nerve. 2019 Jul;60(1):98-103. doi: 10.1002/mus.26486. Epub 2019 Apr 29.
5 Genetic interaction of hnRNPA2B1 and DNAJB6 in a Drosophila model of multisystem proteinopathy.Hum Mol Genet. 2016 Mar 1;25(5):936-50. doi: 10.1093/hmg/ddv627. Epub 2016 Jan 6.
6 Mutation in GNE Downregulates Peroxiredoxin IV Altering ER Redox Homeostasis.Neuromolecular Med. 2017 Dec;19(4):525-540. doi: 10.1007/s12017-017-8467-5. Epub 2017 Sep 11.
7 Editor's Highlight: Effects of Intraperitoneal Injection of SnS2 Flowers on Mouse Testicle.Toxicol Sci. 2018 Feb 1;161(2):388-400. doi: 10.1093/toxsci/kfx220.
8 PACAP38-Mediated Bladder Afferent Nerve Activity Hyperexcitability and Ca(2+) Activity in Urothelial Cells from Mice.J Mol Neurosci. 2019 Jul;68(3):348-356. doi: 10.1007/s12031-018-1119-x. Epub 2018 Jul 19.
9 KIR gene variability in cutaneous malignant melanoma: influence of KIR2D/HLA-C pairings on disease susceptibility and prognosis.Immunogenetics. 2013 May;65(5):333-43. doi: 10.1007/s00251-013-0682-0. Epub 2013 Jan 31.
10 Molecular modeling of the bifunctional enzyme UDP-GlcNAc 2-epimerase/ManNAc kinase and predictions of structural effects of mutations associated with HIBM and sialuria.Glycobiology. 2010 Mar;20(3):322-37. doi: 10.1093/glycob/cwp176. Epub 2009 Nov 16.
11 SQSTM1 splice site mutation in distal myopathy with rimmed vacuoles.Neurology. 2015 Aug 25;85(8):665-74. doi: 10.1212/WNL.0000000000001864. Epub 2015 Jul 24.
12 Technical standards for the interpretation and reporting of constitutional copy-number variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics (ACMG) and the Clinical Genome Resource (ClinGen). Genet Med. 2020 Feb;22(2):245-257. doi: 10.1038/s41436-019-0686-8. Epub 2019 Nov 6.
13 Clinical spectrum of valosin containing protein (VCP)-opathy.Muscle Nerve. 2016 Jun;54(1):94-9. doi: 10.1002/mus.24980. Epub 2015 Dec 29.
14 Catalase A is involved in the response to photooxidative stress in Pseudomonas aeruginosa.Photodiagnosis Photodyn Ther. 2018 Jun;22:233-240. doi: 10.1016/j.pdpdt.2018.04.016. Epub 2018 Apr 27.
15 Evidence for a dominant-negative effect in ACTA1 nemaline myopathy caused by abnormal folding, aggregation and altered polymerization of mutant actin isoforms.Hum Mol Genet. 2004 Aug 15;13(16):1727-43. doi: 10.1093/hmg/ddh185. Epub 2004 Jun 15.
16 The Interaction of UDP-N-Acetylglucosamine 2-Epimerase/N-Acetylmannosamine Kinase (GNE) and Alpha-Actinin 2 Is Altered in GNE Myopathy M743T Mutant.Mol Neurobiol. 2017 May;54(4):2928-2938. doi: 10.1007/s12035-016-9862-x. Epub 2016 Mar 29.
17 1,25(OH)2D3 Induces Actin Depolymerization in Endometrial Carcinoma Cells by Targeting RAC1 and PAK1.Cell Physiol Biochem. 2016;40(6):1455-1464. doi: 10.1159/000453197. Epub 2016 Dec 20.
18 The novel CaMKII inhibitor GS-680 reduces diastolic SR Ca leak and prevents CaMKII-dependent pro-arrhythmic activity.J Mol Cell Cardiol. 2018 May;118:159-168. doi: 10.1016/j.yjmcc.2018.03.020. Epub 2018 Mar 31.
19 Quantification of lectin fluorescence in GNE myopathy muscle biopsies.Muscle Nerve. 2018 Aug;58(2):286-292. doi: 10.1002/mus.26135. Epub 2018 Apr 23.
20 Brain metastases in non-small cell lung cancer patients on epidermal growth factor receptor tyrosine kinase inhibitors: symptom and economic burden.J Med Econ. 2017 Nov;20(11):1136-1147. doi: 10.1080/13696998.2017.1361960. Epub 2017 Aug 14.
21 Myopathies resulting from mutations in sarcomeric proteins.Curr Opin Neurol. 2004 Oct;17(5):529-37. doi: 10.1097/00019052-200410000-00003.
22 (18)F-Positron Emitting/Trimethine Cyanine-Fluorescent Contrast for Image-Guided Prostate Cancer Management.J Med Chem. 2018 May 10;61(9):4256-4262. doi: 10.1021/acs.jmedchem.8b00240. Epub 2018 Apr 20.
23 'Amish Nemaline Myopathy' in 2 Italian siblings harbouring a novel homozygous mutation in Troponin-I gene.Neuromuscul Disord. 2019 Oct;29(10):766-770. doi: 10.1016/j.nmd.2019.09.005. Epub 2019 Sep 6.
24 Missing genetic variations in GNE myopathy: rearrangement hotspots encompassing 5'UTR and founder allele.J Hum Genet. 2017 Feb;62(2):159-166. doi: 10.1038/jhg.2016.134. Epub 2016 Nov 10.